TRANSIENT INTRACELLULAR CALCIUM OSCILLATIONS were the first signaling mediator described to regulate contraction-stimulated glucose transport in skeletal muscle (6) . Thirty years later, the discoveries, that 5Ј-AMP-activated protein kinase (AMPK) activator 5-aminoimidazole-4-carboxamide 1-␤-D-ribofuranoside (AICAR) stimulated glucose transport in skeletal muscle and that muscle contraction activated AMPK, positioned this cellular energy sensor as a potential central regulator of glucose transport in skeletal muscle (5, 10) . Subsequent research has unfolded a complex association between AMPK activation and muscle contraction that depends on the exercise/contraction protocol, its intensity and duration, muscle fiber type, AMPK subunit composition, and even the strain and species from which the muscle is derived (2, 3, 7, 13) . Studies have suggested that contraction-induced changes in intracellular calcium and ␣2-containing heterotrimeric AMPK complexes contribute additive signaling inputs into the stimulation of muscle glucose transport (14, 15) , while another study has shown that increased intracellular calcium and the less abundant ␣1-containing heterotrimeric AMPK complexes may in fact link through calmodulin kinase kinase to regulate contraction-stimulated muscle glucose transport (7) .
In this issue, Blair et al.
(1) used a potent inhibitor of type II fast-twitch skeletal muscle myosin ATPase, N-benzyl-p-toluene sulfonamide (BTS), to markedly inhibit force production in electrically stimulated rat epitrochlearis muscle, thereby reducing energy demand and contraction-stimulated AMPK phosphorylation. Interestingly, this treatment only partly inhibited glucose transport. BTS did not inhibit glucose transport stimulated by the AMPK activator AICAR or calcium ion flux in electrically stimulated muscle (indirectly shown by the persistence of calmodulin kinase II phosphorylation). Thus, depolarization-induced changes in intracellular calcium may mediate a portion of the contraction-stimulated glucose transport that remains unaffected by BTS treatment.
This study raises important questions regarding the energy demand threshold for AMPK activation in muscle. Rapid energy supply, possibly relying on fuel stores within the muscle, may adequately cope with repetitive depolarization in the presence of BTS (given the lack of cross-bridge cycling) such that AMPK is not activated. Overt contraction may overcome the threshold, engaging AMPK to increase influx of glucose and lipid for oxidation.
Recently, our understanding of connections between AMPK and muscle glucose uptake were crystalized when AMPK was shown to phosphorylate Akt-substrate of 160 kDa (AS160/ TBC1D4) (8, 12) , and a mutant form of AS160/TBC1D4 interfered with contraction-stimulated muscle glucose transport (9) . AS160/TBC1D4 is a putative Rab-GAP best known for its role in insulin-stimulated glucose transport (16), but a highly related protein, TBC1D1, is also phosphorylated in response to contraction (4, 11 
